(Q73042492)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10506726%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Erythropoietin reduces anemia and transfusions: A randomized trial with or without erythropoietin during chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10506726%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

F R Dunphy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10506726%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

B R Harrison

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10506726%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

T L Dunleavy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10506726%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J J Rodriguez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10506726%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J G Hilton

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10506726%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J H Boyd

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10506726%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 October 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10506726%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10506726%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10506726%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10506726%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

1362-1367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10506726%20AND%20SRC:MED&resulttype=core&format=json

Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1362%3A%3AAID-CNCR36%3E3.0.CO%3B2-T

Erythropoietin reduces anemia and transfusions after chemotherapy with paclitaxel and carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1362%3A%3AAID-CNCR36%3E3.0.CO%3B2-T

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1362%3A%3AAID-CNCR36%3E3.0.CO%3B2-T

Serum erythropoietin levels in gynecologic cancer patients during cisplatin combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1362%3A%3AAID-CNCR36%3E3.0.CO%3B2-T

Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1362%3A%3AAID-CNCR36%3E3.0.CO%3B2-T

Phase I-II Trial of Erythropoietin in the Treatment of Cisplatin-Associated Anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1362%3A%3AAID-CNCR36%3E3.0.CO%3B2-T

Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1362%3A%3AAID-CNCR36%3E3.0.CO%3B2-T

Taxol (paclitaxel) in patients with metastatic breast carcinoma who have failed prior chemotherapy: interim results of a multinational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1362%3A%3AAID-CNCR36%3E3.0.CO%3B2-T

Paclitaxel in metastatic breast cancer: a trial of two doses by a 3-hour infusion in patients with disease recurrence after prior therapy with anthracyclines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1362%3A%3AAID-CNCR36%3E3.0.CO%3B2-T

Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1362%3A%3AAID-CNCR36%3E3.0.CO%3B2-T

Phase I trial of 3-hour infusion of paclitaxel with or without granulocyte colony-stimulating factor in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1362%3A%3AAID-CNCR36%3E3.0.CO%3B2-T

Three-hour paclitaxel infusion in patients with refractory and relapsed non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1362%3A%3AAID-CNCR36%3E3.0.CO%3B2-T

Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1362%3A%3AAID-CNCR36%3E3.0.CO%3B2-T

Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1362%3A%3AAID-CNCR36%3E3.0.CO%3B2-T

Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1362%3A%3AAID-CNCR36%3E3.0.CO%3B2-T

Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991001%2986%3A7%3C1362%3A%3AAID-CNCR36%3E3.0.CO%3B2-T

10.1002/(SICI)1097-0142(19991001)86:7<1362::AID-CNCR36>3.0.CO;2-T

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10506726%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference